Glycodynamics of Mucin Biosynthesis in Gastrointestinal Tumor Cells
- 1 January 2003
- book chapter
- Published by Springer Nature
- Vol. 535, 163-188
- https://doi.org/10.1007/978-1-4615-0065-0_11
Abstract
Glycoproteins found in the secretions and on the surfaces of cancer cells include mucins and mucin-like glycoproteins. These molecules have been shown to carry antigens that are characteristically expressed on cancer cells, including Tn and T antigens and Lewis epitopes. The structures of O-glycans are often abnormal in gastrointestinal tumors, or else are present in abnormal amounts, and these structures greatly contribute to the phenotype and biology of cancer cells. It has been shown that glycans of cancer cells have functional importance in cell adhesion, invasion and metastasis. The possible mechanisms leading to these cancer-specific changes in carbohydrate structures (termed glycodynamics) involve altered mRNA expression and catalytic activities of glycosyltransferases and sulfotrans-ferases found in tissues and cells of gastrointestinal tumors. In a number of cases it has been possible to correlate enzyme changes with oligosaccharide structures. Different mechanisms have been suggested leading to the synthesis of cancer-specific Lewis, T and Tn antigens, but the regulation of cancer mucin antigens generally appears to be very complex and is poorly understood. The expression levels of specific mucin antigens and enzymes in gastro-intestinal tumors have diagnostic as well as prognostic value. These antigens also have potential for cancer immunotherapy. However, we first need to unravel the complexity of the control of glycosylation in cancer cells. Most importantly, studies of the functional implications of the glycodynamics in cancer cells, as related to cell adhesion and impact on the immune system will provide promising directions for future research.Keywords
This publication has 130 references indexed in Scilit:
- A novel β1,3-N-acetylglucosaminyltransferase involved in invasion of cancer cells as assayed in vitroBiochemical and Biophysical Research Communications, 2002
- MUC17, a Novel Membrane-Tethered MucinBiochemical and Biophysical Research Communications, 2002
- Molecular Cloning and Characterization of a Novel Human Galactose 3-O-Sulfotransferase That Transfers Sulfate to Galβ1→3GalNAc Residue in O-GlycansJournal of Biological Chemistry, 2001
- β-galactoside α2,6 sialyltransferase in human colon cancer: contribution of multiple transcripts to regulation of enzyme activity and reactivity withsambucus nigra agglutininInternational Journal of Cancer, 2000
- Cloning and Characterization of a Mammalian N-Acetylglucosamine-6-sulfotransferase That Is Highly Restricted to Intestinal TissueBiochemical and Biophysical Research Communications, 1999
- Differential expression of β1,3galactosyltransferases in human colon cells derived from adenocarcinomas or normal mucosa1FEBS Letters, 1999
- Cell SurfaceN-Acetylneuraminic Acid α2,3-Galactoside-Dependent Intercellular Adhesion of Human Colon Cancer CellsBiochemical and Biophysical Research Communications, 1999
- UDPgalactose:glycoprotein–N‐acetyl‐d‐galactosamine 3‐β‐d‐galactosyltransferase activity synthesizing O‐glycan core 1 is controlled by the amino acid sequence and glycosylation of glycopeptide substratesEuropean Journal of Biochemistry, 1994
- Inhibition of selectin-dependent tumor cell adhesion to endothelial cells and platelets by blocking O-glycosylation of these cellsBiochemical and Biophysical Research Communications, 1992
- UDP‐GalNAc : GalNAc‐mucin α‐N‐acetylgalactosamine transferase activity in human intestinal cancerous tissuesFEBS Letters, 1985